Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Thrombosis
Trial Information
Have you or someone you know been recently diagnosed with a Deep Vein Thrombosis (DVT). If so, please contact Crystal Nagle at 610-988-4308 and see if this study might be for you.
A 2 year study for patients following treatment of an Acute DVT with the drug Activase. This study is being funded by the NIH (National Institution of Health) and sponsored by Washington University in St. Louis, Missouri.
Patient Inclusion Criteria:
- Acute Deep Vein Thrombosis (DVT) of the iliac, common femoral and/or femoral vein.
- Patients 16-70 years of age.
Patient Exclusion Criteria:
- Chronic DVT or current DVT symptoms for greater than 14 days.
- Previous DVT in the affected let within the last 2 years or previous DVT of the unaffected leg within the last month.
- Severe kidney impairment.
- Allergy to drugs, Heparin or Activase.
- Active cancer except patients with non-melanoma skin cancer.
- Chronic non-ambulatory patients.
- Patients who are pregnant.
Crystal Nagle, Clinical Trials Administrator
The Reading Hospital and Medical Center Clinical Trials Office
Sixth Ave and Spruce Street, R-Building, 4th Floor
West Reading, PA 19611
Phone: 610-988-4308
Fax: 610-988-8334
EMail: naglec@readinghospital.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
